Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle D Apley

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Molecular Pharmaceutics|July 6, 2023
Multivalent Scaffolds to Promote B cell ToleranceStephanie N Johnson, Spencer D Brucks, Kyle D Apley, et al.
Journal of Visualized Experiments : Jove|November 9, 2020
Tetrameric Fluorescent Antigen Arrays for Single-Step Identification of Antigen-Specific B CellsKyle D Apley, J Daniel Griffin, Stephanie N Johnson, et al.
Molecular Pharmaceutics|November 12, 2025
Engineered Nonhormonal, Cationic Proinsulin Variants Prolong Lymphatic DrainageGrant M Downes, Amber S Griffith, Kyle D Apley, et al.
ACS Applied Bio Materials|February 4, 2026
Soluble Antigen Arrays Alter the Response of Epitope-Specific Diabetogenic T CellsGrant M Downes, Camillo Bechi Genzano, Colin R Silva, et al.
Bioconjugate Chemistry|October 26, 2023
CD22L Conjugation to Insulin Attenuates Insulin-Specific B Cell ActivationKyle D Apley, Amber S Griffith, Grant M Downes, et al.
ACS Pharmacology & Translational Science|November 21, 2022
Disrupting N-Glycosylation Using Type I Mannosidase Inhibitors Alters B-Cell Receptor SignalingAric Huang, Suresh E Kurhade, Patrick Ross, et al.
Industrial & Engineering Chemistry Research|April 22, 2024
Optimized Production of Fc Fusion Proteins by Sortase Enzymatic LigationKyle D Apley, Amy D Laflin, Stephanie N Johnson, et al.
Drug Delivery and Translational Research|May 22, 2025
Evaluation of proinsulin(F25D) as a targeting ligand for insulin-binding B cells in autoimmune diabetesKyle D Apley, Lindsay E Bass, Jaylyn King, et al.
Molecular Pharmaceutics|January 23, 2026
Soluble Antigen Array Displaying Proinsulin(F25D) Selectively Targets Anti-insulin B Cells without Hormonal EffectsGrant M Downes, Kyle D Apley, Gang Hu, et al.
Antibiotics (Basel, Switzerland)|February 26, 2025
Impact of Hydrophobic, Hydrophilic, and Mucus-Binding Motifs on the Therapeutic Potential of Ceftazidime Analogs for Pulmonary AdministrationKyle D Apley, Stephanie N Johnson, Jian Qian, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Molecular Pharmaceutics|July 6, 2023
Multivalent Scaffolds to Promote B cell ToleranceStephanie N Johnson, Spencer D Brucks, Kyle D Apley, et al.
Journal of Visualized Experiments : Jove|November 9, 2020
Tetrameric Fluorescent Antigen Arrays for Single-Step Identification of Antigen-Specific B CellsKyle D Apley, J Daniel Griffin, Stephanie N Johnson, et al.
Molecular Pharmaceutics|November 12, 2025
Engineered Nonhormonal, Cationic Proinsulin Variants Prolong Lymphatic DrainageGrant M Downes, Amber S Griffith, Kyle D Apley, et al.
ACS Applied Bio Materials|February 4, 2026
Soluble Antigen Arrays Alter the Response of Epitope-Specific Diabetogenic T CellsGrant M Downes, Camillo Bechi Genzano, Colin R Silva, et al.
Bioconjugate Chemistry|October 26, 2023
CD22L Conjugation to Insulin Attenuates Insulin-Specific B Cell ActivationKyle D Apley, Amber S Griffith, Grant M Downes, et al.
ACS Pharmacology & Translational Science|November 21, 2022
Disrupting N-Glycosylation Using Type I Mannosidase Inhibitors Alters B-Cell Receptor SignalingAric Huang, Suresh E Kurhade, Patrick Ross, et al.
Industrial & Engineering Chemistry Research|April 22, 2024
Optimized Production of Fc Fusion Proteins by Sortase Enzymatic LigationKyle D Apley, Amy D Laflin, Stephanie N Johnson, et al.
Drug Delivery and Translational Research|May 22, 2025
Evaluation of proinsulin(F25D) as a targeting ligand for insulin-binding B cells in autoimmune diabetesKyle D Apley, Lindsay E Bass, Jaylyn King, et al.
Molecular Pharmaceutics|January 23, 2026
Soluble Antigen Array Displaying Proinsulin(F25D) Selectively Targets Anti-insulin B Cells without Hormonal EffectsGrant M Downes, Kyle D Apley, Gang Hu, et al.
Antibiotics (Basel, Switzerland)|February 26, 2025
Impact of Hydrophobic, Hydrophilic, and Mucus-Binding Motifs on the Therapeutic Potential of Ceftazidime Analogs for Pulmonary AdministrationKyle D Apley, Stephanie N Johnson, Jian Qian, et al.
Pageof 2